CROSSJECT (EPA:ALCJ) | WebDisclosure

PRESS RELEASE

published on 03/25/2025 at 07:30, 10 months 26 days ago

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
CROSSJECT enhances collaboration with ETON PHARMACEUTICALS Inc. on ZENEO adrenal insufficiency program, introducing new hydrocortisone formulation for the hospital market

Eton Pharmaceuticals Crossject Hydrocortisone Adrenal Insufficiency ZENEO
BRIEF

published on 03/10/2025 at 14:22, 11 months 10 days ago

Crossject : Mise à jour sur les droits de vote et actions au 31 janvier 2025

Droits De Vote Capital Social Actions Pharmaceutique Crossject
BRIEF

published on 03/10/2025 at 14:22, 11 months 10 days ago

Crossject: Update on voting rights and shares as of January 31, 2025

Share Capital Voting Rights Actions Pharmaceutical Crossject
PRESS RELEASE

published on 03/10/2025 at 14:17, 11 months 10 days ago

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
Crossject communique le nombre total de droits de vote et d’actions composant son capital social au 31 janvier 2025, conformément aux règlements de l’AMF et du Code de commerce

Droits De Vote Capital Social Pharmaceutique Communiqué Crossject
BRIEF

published on 02/12/2025 at 07:35, 1 year ago

Crossject Reappoints Key Members to Executive Board

Executive Board Crossject ZEPIZURE® Reappointment Needle-free Technology
BRIEF

published on 02/12/2025 at 07:35, 1 year ago

Crossject renouvelle le mandat de membres clés de son conseil d'administration

Conseil Exécutif Crossject ZEPIZURE® Renouvellement De Nomination Technologie Sans Aiguille
PRESS RELEASE

published on 02/12/2025 at 07:30, 1 year ago

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board
Crossject reappoints Patrick Alexandre and Isabelle Liebschutz to its Executive Board, focusing on final stages of ZEPIZURE registration with the FDA

Executive Board Crossject Patrick Alexandre Isabelle Liebschutz ZEPIZURE Registration
PRESS RELEASE

published on 02/12/2025 at 07:30, 1 year ago

Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré
Crossject renouvelle Patrick Alexandre et Isabelle Liebschutz au sein d'un nouveau Directoire resserré pour se concentrer sur l'enregistrement du ZEPIZURE® auprès de la FDA et la commercialisation aux Etats-Unis

FDA Renouvellement Crossject ZEPIZURE® Directoire
BRIEF

published on 02/06/2025 at 07:35, 1 year ago

Modification des Obligations Convertibles par Crossject

Financement Obligations Convertibles Crossject ZEPIZURE Heights Capital
BRIEF

published on 02/06/2025 at 07:35, 1 year ago

Modification of Convertible Bonds by Crossject

Convertible Bonds Funding Crossject ZEPIZURE Heights Capital

Published on 02/21/2026 at 00:45, 1 hour 29 minutes ago

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 hour 44 minutes ago

Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 2 hours 59 minutes ago

DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 3 hours 14 minutes ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 3 hours 57 minutes ago

Organto Foods Completes Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 02/20/2026 at 18:36, 7 hours 38 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 7 hours 43 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 7 hours 51 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 8 hours 14 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 8 hours 14 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS

Published on 02/20/2026 at 19:29, 6 hours 45 minutes ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 6 hours 45 minutes ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 8 hours 14 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 8 hours 14 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 8 hours 39 minutes ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News